Quality Care Of Waco Medicare and Medicaid Location: 2501 Maple Ave, Waco, Texas 76707 Ratings: Phone: (254) 752-0311 |
Jeffrey Place Healthcare Center Medicare and Medicaid Location: 820 Jeffrey Dr, Waco, Texas 76710 Ratings: Phone: (254) 772-9480 |
Greenview Manor Medicare and Medicaid Location: 401 Owen Ln, Waco, Texas 76710 Ratings: Phone: (254) 772-8900 |
Ridgecrest Retirement And Healthcare Community Medicare and Medicaid Location: 1900 W State Hwy 6, Waco, Texas 76712 Ratings: Phone: (254) 776-9681 |
St. Catherine Center Medicare and Medicaid Location: 300 West Highway 6, Waco, Texas 76712 Ratings: Phone: (254) 761-8500 |
Crestview Healthcare Residence Medicare and Medicaid Location: 1400 Lake Shore Dr, Waco, Texas 76708 Ratings: Phone: (254) 753-0291 |
Woodland Springs Nursing Center Medicare and Medicaid Location: 1010 Dallas St, Waco, Texas 76704 Ratings: Phone: (254) 752-9774 |
Lake Shore Village Healthcare Center Medicare and Medicaid Location: 2320 Lake Shore Dr, Waco, Texas 76708 Ratings: Phone: (254) 752-1075 |
Regent Care Center Of Woodway Medicare and Medicaid Location: 7801 Woodway Dr, Waco, Texas 76712 Ratings: Phone: (254) 235-7801 |
Wesley Woods Health & Rehabilitation Medicare and Medicaid Location: 1700 Woodgate Drive, Waco, Texas 76712 Ratings: Phone: (254) 666-5454 |
Royal Manor Medicare and Medicaid Location: 9101 Panther Way, Waco, Texas 76712 Ratings: Phone: (254) 537-9200 |
The Brazos Of Waco Medicare and Medicaid Location: 2430 Market Place Drive, Waco, Texas 76711 Ratings: Phone: (254) 981-7900 |
St. Anthony's Care Center Medicare and Medicaid Location: 7501 Bagby Ave., Waco, Texas 76712 Ratings:NA Phone: (254) 666-8003 |
News Archive
The consumer advocacy group Public Citizen on Thursday sent a letter to acting FDA Commissioner Andrew von Eschenbach asking the agency to conduct a criminal investigation into whether Santa Barbara, Calif.-based Mentor intentionally withheld safety data on its silicone breast implant application, the Washington Post reports.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
Researchers who collect genetic samples from children for medical research need to explain the process more clearly to parents, according to a new study that suggests many parents don't fully understand the finer details about how these samples will be used and stored. The study was published in June in Genetics in Medicine.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
› Verified 2 days ago